Jonathan R. Strosberg, Tyler J. Zemla, Susan Michelle Geyer, Michael V. Knopp, Spencer Behr, Sydney Pulsipher, Jared David Acoba, Ardaman Shergill, Edward M. Wolin, Thorvardur Ragnar Halfdanarson, Bhavana Konda, Nikolaos Trikalinos, Bernard Tawfik, Nitya Prabhakar Raj, Shagufta Shaheen, Namrata Vijayvergia, Arvind Dasari, Eileen M. O'Reilly, Jeffrey A. Meyerhardt, Jennifer A. Chan. "Efficacy and safety of cabozantinib for advanced gastrointestinal (GI) neuroendocrine tumors (NET) after progression on prior therapy: Subgroup analysis of the phase 3 CABINET trial (Alliance A021602).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.4_suppl.666